The lifting of veterinary regulations to allow animals to be moved to safety during Ukraine's humanitarian crisis is unprecedented. Dorien Braam argues for this approach to be replicated in other refugee contexts.
Long-term use of implantable electronic medical devices – such as pacemakers and cochlear implants – is hampered by the body’s reaction to foreign bodies. Now, in a study in mice, a team led by scientists at the University of Cambridge has shown that this reaction can be dramatically reduced by incorporating an anti-inflammatory drug into the silicone coating around the implant.
Prime Minister Boris Johnson announced that DIOSynVax, a biotech spinout of the University of Cambridge, will receive $42 million (about £32 million) to develop a vaccine candidate that could provide protection against both existing and future variants of SARS-CoV-2 – the virus that causes COVID-19 – as well as other major coronaviruses, including those that cause SARS and MERS.
Scientists have found evidence that a type of the antibiotic-resistant superbug MRSA arose in nature long before the use of antibiotics in humans and livestock, which has traditionally been blamed for its emergence.
Safety trials are underway for a vaccine developed by Cambridge researchers that could be used as a booster targeting COVID-19 virus variants and relatives that threaten future coronavirus pandemics.
Rising resistance to antibiotics is a worrying prospect, but a success story happening across the farms of the UK gives hope that something can be done.
Are we in for a bad flu season this winter? Cambridge experts who have been studying flu for decades consider the scenarios that may lie ahead.
Carnivorous animals lack key genes needed to detect and respond to infection by pathogens, a study has found.
The Trinity Challenge has announced the winners of its inaugural competition, and is investing a £5.7 million (US$8 million) charitable pledged prize fund into one grand prize winner, two 2nd prize winners, and five 3rd prize winners.
Scientists have been able to track how a multi-drug resistant organism is able to evolve and spread widely among cystic fibrosis patients – showing that it can evolve rapidly within an individual during chronic infection.
© 2024 University of Cambridge